Ignite Creation Date:
2025-12-24 @ 11:04 PM
Ignite Modification Date:
2026-03-04 @ 8:38 PM
Study NCT ID:
NCT03209869
Status:
WITHDRAWN
Last Update Posted:
2022-09-13
First Post:
2017-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Expanded Haploidentical NK Cells and Hu14.18-IL2
Sponsor:
University of Wisconsin, Madison
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-07
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-13
First Submit QC Date:
None
Study First Post Date:
2017-07-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-12
Last Update Post Date:
2022-09-13
Last Update Post Date Type:
ACTUAL